Science Explorer Interactive view Map
Hospital / health system · Fayetteville · United States

Highlands Oncology Group

highlandsoncologygroup.comROR OpenAlex
Research works
77
◆ 1% vs 2013–17
Citations
1.4k
18.4 per fractional work
Top-10% rate
12.3%
record average 16.5%
Open access
34%
world 28%

Not ranked overall: Highlands Oncology Group is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.42× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 3.67× its world share, 3 worksBiochemistry, Geneti…Immunology and Microbiology: 3.40× its world share, 1 worksImmunology and Micro…Neuroscience: 0.89× its world share, 0 worksNeuroscienceChemistry: 3.91× its world share, 1 worksChemistryComputer Science: 0.24× its world share, 0 worksComputer ScienceEngineering: 0.29× its world share, 1 worksEngineeringEnvironmental Science: 0.60× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.28× its world share, 0 worksMaterials ScienceMathematics: 0.84× its world share, 0 worksMathematicsHealth Professions: 0.25× its world share, 0 worksHealth ProfessionsMedicine: 2.43× its world share, 8 worksMedicineArts and Humanities: 1.63× its world share, 1 worksArts and HumanitiesEconomics, Econometrics and Finance: 0.93× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.17× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Chemistry, 3.9×. Every wedge is a field page.

Who are the top researchers at Highlands Oncology Group?

Ranked on the composite score, J. Thaddeus Beck lead among researchers whose main affiliation is Highlands Oncology Group.

  1. 1 J. Thaddeus Beck United States · #776,732 worldwide 83 citations · 41 works
All ranked researchers at Highlands Oncology Group

Which keywords describe research at Highlands Oncology Group?

By fractional works in all years, weighted toward what it does more of than the world: Breast Cancer, Chemotherapy, Metastatic Breast Cancer, Targeted Therapy, Clinical Trials, Cell Cycle Control, CDK4/6 Inhibitors and Palbociclib.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Breast Cancer10▲ 44×7 topics
  2. Chemotherapy8▲ 15×13 topics
  3. Metastatic Breast Cancer8▲ 152×2 topics
  4. Targeted Therapy7▲ 40×4 topics
  5. Clinical Trials6▲ 12×5 topics
  6. Cell Cycle Control6▲ 294×2 topics
  7. CDK4/6 Inhibitors6▲ 448×1 topic
  8. Palbociclib6▲ 448×1 topic
  9. Prognostic Factors5▲ 14×10 topics
  10. Immunotherapy5▲ 9.3×12 topics
  11. Quality of Life4▲ 4.2×9 topics
  12. Metastasis4▲ 14×6 topics
  13. Radiotherapy4▲ 13×9 topics
  14. Biomarkers3▲ 6.7×5 topics
  15. Molecular Subtypes3▲ 46×3 topics
  16. Clinical Practice Guidelines3▲ 6.8×6 topics
  17. Genomic Profiles3▲ 105×1 topic
  18. Small-Cell Lung Cancer3▲ 105×1 topic
  19. ALK Inhibitors3▲ 63×1 topic
  20. EGFR Mutations3▲ 63×1 topic
  21. Genomic Profiling3▲ 36×2 topics
  22. Tumor Microenvironment3▲ 9.8×5 topics
  23. Signaling3▲ 29×3 topics
  24. Survival Analysis3▲ 12×4 topics
  25. Neoadjuvant Therapy2▲ 14×4 topics
  26. Cancer Therapy2▲ 4.7×10 topics
  27. Chemotherapy-Induced Peripheral Neuropathy2▲ 58×1 topic
  28. Taxanes2▲ 58×1 topic
  29. Surgical Management2▲ 6.2×7 topics
  30. Metastatic2▲ 41×2 topics
  31. Precision Medicine2▲ 8.5×5 topics
  32. Receptor tyrosine kinases2▲ 54×2 topics
  33. Breast Tumours2▲ 47×1 topic
  34. Immune Checkpoint Blockade2▲ 41×1 topic
  35. PD-1 and PD-L12▲ 41×1 topic
  36. Treatment Response2▲ 47×1 topic
  37. Monoclonal Antibody2▲ 31×2 topics
  38. Cell Growth2▲ 60×2 topics
  39. HER22▲ 70×1 topic
  40. Trastuzumab2▲ 50×1 topic

Which research topics does Highlands Oncology Group publish most on?

By volume in 2022–2025: Biological Activity of Diterpenoids and Biflavonoids, Advanced Breast Cancer Therapies, Cancer Treatment and Pharmacology and HER2/EGFR in Cancer Research.

Biological Activity of Diterpenoids and Biflavonoids: 1 fractional worksAdvanced Breast Cancer Therapies: 1 fractional worksCancer Treatment and Pharmacology: 1 fractional worksHER2/EGFR in Cancer Research: 0 fractional worksLung Cancer Treatments and Mutations: 0 fractional worksAir Quality Monitoring and Forecasting: 0 fractional worksLung Cancer Research Stu…0Lung Cancer Research Studies: 0 fractional worksVehicle emissions and performance: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksSynthesis and biological…0Synthesis and biological activity: 0 fractional works
Molecular BiologyPulmonary and Respiratory MedicineOncologyEnvironmental Engineering2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Biological Activity of Diterpenoids and Biflavonoids Molecular Biology 1 works
  2. 2 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 1 works
  3. 3 Cancer Treatment and Pharmacology Oncology 1 works
  4. 4 HER2/EGFR in Cancer Research Oncology 0 works
  5. 5 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  6. 6 Air Quality Monitoring and Forecasting Environmental Engineering 0 works
  7. 7 Lung Cancer Research Studies Oncology 0 works
  8. 8 Vehicle emissions and performance Automotive Engineering 0 works
  9. 9 Cancer Immunotherapy and Biomarkers Oncology 0 works
  10. 10 Synthesis and biological activity Organic Chemistry 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available34.0%not open66.0%

World: 28% of research is openly available.

with international co-authors29.0%domestic only71.0%

World: 19% is written across borders.

How has Highlands Oncology Group's research output changed?

Output in 2018–2022 was 1% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Fayetteville

All research institutions in Fayetteville

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.